Evidence-Based Quality Scores for Rating Drug Products and Their Utility in Health Systems
Arash Dabestani, Carl W Bazil, Ryan C Costantino, Erin Fox, Joe Graedon, Harry Lever, Robert Makuch, C Michael White
doi: https://doi.org/10.1101/2020.05.22.20110775
Arash Dabestani
1 NYU Langone Health;
Carl W Bazil
2 Columbia University Medical Center;
Ryan C Costantino
3 USA MEDCOM Pharmacy Service Line, Defense Health Agency;
Erin Fox
4 Department of Pharmacy, University of Utah Health Care;
Joe Graedon
5 Peoples Pharmacy;
Harry Lever
6 Cleveland Clinic;
Robert Makuch
7 Yale School of Medicine;
C Michael White
8 University of Connecticut School of Pharmacy

Data Availability
THere are no patient/human subject data included in this manuscript
Posted August 26, 2020.
Evidence-Based Quality Scores for Rating Drug Products and Their Utility in Health Systems
Arash Dabestani, Carl W Bazil, Ryan C Costantino, Erin Fox, Joe Graedon, Harry Lever, Robert Makuch, C Michael White
medRxiv 2020.05.22.20110775; doi: https://doi.org/10.1101/2020.05.22.20110775
Subject Area
Subject Areas
- Addiction Medicine (62)
- Allergy and Immunology (144)
- Anesthesia (47)
- Cardiovascular Medicine (419)
- Dermatology (49)
- Emergency Medicine (147)
- Epidemiology (4906)
- Gastroenterology (185)
- Geriatric Medicine (72)
- Health Economics (193)
- Health Informatics (636)
- Health Policy (322)
- Hematology (86)
- HIV/AIDS (157)
- Medical Education (96)
- Medical Ethics (24)
- Nephrology (77)
- Neurology (692)
- Nursing (42)
- Nutrition (115)
- Oncology (447)
- Ophthalmology (140)
- Orthopedics (36)
- Otolaryngology (91)
- Pain Medicine (37)
- Palliative Medicine (18)
- Pathology (131)
- Pediatrics (201)
- Public and Global Health (1832)
- Radiology and Imaging (328)
- Respiratory Medicine (257)
- Rheumatology (87)
- Sports Medicine (63)
- Surgery (102)
- Toxicology (23)
- Transplantation (29)
- Urology (38)